Novavax, Inc. (NVAX)

Check out top investors' recommendation for NVAX
Last closing price (N/A)
(0.00%) ? 
Last closing price is the stock price upon last market close (date specified in parenthesis).
Return to date (1m/3m/6m/12m):
N/A ? 
Return to date is the stock return for the specified period of time.
Consensus price target (1m/3m/6m/12m):
2.75
 ? 
Consensus price target is the average analyst price target for a specified period of time.
Buy/Sell Mix (1m/3m/6m/12m):
67%/33%
 ? 
Buy/sell mix the percentage mix between Buy and Sell recommendations for a given company or a research firm. Hold recommendations are excluded.
Description:
Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on developing recombinant protein nanoparticle vaccines to address a range of infectious diseases. The company’s technology platform is based on proprietary recombinant vaccine technology that includes virus-like particles (VLPs) and recombinant protein micelle vaccines. Its vaccine candidates target seasonal influenza, pandemic (H5N1) influenza, and respiratory syncytial virus (RSV). The company, through its joint venture, CPL Biologics Private Limited, engages in developing seasonal and pandemic influenza, and rabies vaccine candidates. The company has a licensing agreement with LG Life Sciences, Ltd. to use the company’s VLP technology to develop and sell the influenza vaccines in South Korea and other countries; and a clinical development agreement with PATH Vaccine Solutions to develop RSV vaccine candidate. The company was founded in 1987 and is headquartered in Rockville, Maryland.
Sector:
Industry:
Analyst
An analyst is a professional research analyst or an Investor Wand user who issued a recommendation for a given company.
Research Firm
A Research Firm is a company that researches and rates stocks and publishes recommendations.
Signal
Signal is a recommendation issued by an analyst. Investor Wand considers two types of recommendations: BUY and SELL.
Signal Date
A signal date is a date when a BUY or SELL recommendation was issued for given security.
Initial Price
Initial Price is the first closing price for a specified company upon recommendation release. If the recommendation is issued in after-market hours, the Initial Price is the next day’s closing price (for a given symbol). In case of dividend distributions and stock splits, Initial Price is adjusted.
Price Target
A Price Target is an analyst’s projection of a company’s stock price by the end of the recommendation period. It represents the price at which the analyst would exit his or her existing position.
Closing Date
Closing Date is the expiration date of a recommendation. The validity timeframe of a professional analyst’s recommendation is 12 months. Investor Wand analysts can set their recommendation timeframe to one, three, six, or 12 months.
Return
The return on a single open recommendation is calculated as the maximum of the current return (based on the latest closing price) and the target price return, if the symbol reached the target. The return on a single closed recommendation is calculated as the maximum of the return on the closing date (at the end of recommendation timeframe) and the target price return, if the stock hit the target price. The return is adjusted for one-time events (e.g., stock splits).
Kevin Degeeter Ladenburg Thalmann & Co. Buy   Feb 28, '19     1.50  Feb 28, '20  N/A 
Edward Tenthoff Piper Jaffray Sell   Feb 28, '19       Feb 28, '20  N/A 
Kevin Degeeter Ladenburg Thalmann & Co. Buy   Jan 04, '19     4.00  Jan 04, '20  N/A 
Edward Tenthoff Piper Jaffray Buy   Nov 26, '18       Nov 26, '19  N/A 
George Zavoico Mcnicoll, Lewis, & Vlak Buy   Oct 08, '18     10.00  Oct 08, '19  N/A 
George Zavoico Mcnicoll, Lewis, & Vlak Buy   Jun 14, '18     10.00  Jun 14, '19  N/A 
Jessica Fye JPMorgan Sell   Mar 19, '18       Mar 19, '19  N/A 
George Zavoico Mcnicoll, Lewis, & Vlak Buy   Mar 01, '18     10.00  Mar 01, '19  N/A 
Kevin Degeeter Ladenburg Thalmann & Co. Buy   Mar 01, '18     3.50  Mar 01, '19  N/A 
Kevin Degeeter Ladenburg Thalmann & Co. Buy   Jan 11, '18     2.50  Jan 11, '19  N/A 
George Zavoico Mcnicoll, Lewis, & Vlak Buy   Jan 05, '18     2.25  Jan 05, '19  N/A 
Kevin Degeeter Ladenburg Thalmann & Co. Buy   Aug 09, '17       Aug 09, '18  N/A 
Edward Tenthoff Piper Jaffray Buy   Sep 09, '16     14.00  Sep 09, '17  N/A 
Edward Tenthoff Piper Jaffray Buy   Sep 29, '15   6.41    Sep 29, '16  N/A 
Cory Kasimov JPMorgan Buy   Jul 21, '15   12.32    Jul 21, '16  -39.69% 
Gregory Wade Wedbush Securities Inc. Buy   Sep 18, '14   4.48    Sep 18, '15  131.47% 
javi pere Unaffiliated Buy   Jun 21, '14   4.89  12.00  Jun 21, '15  91.82% 
Kevin Degeeter Ladenburg Thalmann & Co. Buy   Mar 11, '14   5.90  10.00  Mar 11, '15  52.88% 
William Tanner Lazard Capital Markets Buy   Aug 15, '13   2.70  11.00  Aug 15, '14  72.22% 
Gregory Wade Wedbush Securities Inc. Buy   Apr 04, '13   2.28  4.00  Apr 04, '14  91.67% 
< previous12